BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Park H, Song HJ, Jiang X, Henry L, Cook RL, Nelson DR. Direct-Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C. Hepatol Commun 2021;5:203-16. [PMID: 33553969 DOI: 10.1002/hep4.1634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Jiang X, Parker RL, Vouri SM, Lo-Ciganic W, Diaby V, Henry L, Park H. Cascade of Hepatitis C Virus Care Among Patients With Substance Use Disorders. Am J Prev Med 2021:S0749-3797(21)00271-3. [PMID: 34210584 DOI: 10.1016/j.amepre.2021.04.013] [Reference Citation Analysis]
2 Wiznia DH, Morgan RC Jr, Gibson D. Movement is Life-Optimizing Patient Access to Total Joint Arthroplasty: HIV and Hepatitis C Disparities. J Am Acad Orthop Surg 2021. [PMID: 34723921 DOI: 10.5435/JAAOS-D-21-00427] [Reference Citation Analysis]
3 Jiang X, Song HJ, Wang W, Henry L, Childs-Kean LM, Re VL 3rd, Park H. The use of all-oral direct-acting antivirals in hepatitis C virus-infected patients with substance use disorders. J Manag Care Spec Pharm 2021;27:873-81. [PMID: 34185563 DOI: 10.18553/jmcp.2021.27.7.873] [Reference Citation Analysis]
4 Park H, Lo-Ciganic WH, Huang J, Wu Y, Henry L, Peter J, Sulkowski M, Nelson DR. Machine learning algorithms for predicting direct-acting antiviral treatment failure in chronic hepatitis C: An HCV-TARGET analysis. Hepatology 2022. [PMID: 35034373 DOI: 10.1002/hep.32347] [Reference Citation Analysis]